Product Images Eribulin Mesylate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Eribulin Mesylate NDC 68083-592 by Gland Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
eribulin-spl-carton-label - eribulin spl carton label
This text is pharmaceutical information for Eribulin Mesylate Injection, a cytotoxic agent used for intravenous administration. It provides details on dosage, usage instructions, storage conditions, and manufacturing information. The medication comes in single-dose vials containing 1 mg of eribulin mesylate in 2 mL of solution. Each mL of solution contains 0.5 mg of eribulin mesylate in dehydrated alcohol and water for injection. The text emphasizes the importance of discarding any unused portion of the solution and provides guidelines on storage temperature.*
eribulin-spl-fig-1 - eribulin spl fig 1
eribulin-spl-fig-2 - eribulin spl fig 2
eribulin-spl-structure - eribulin spl structure
eribulin-spl-vial-label - eribulin spl vial label
This text provides information on a medication called Eribulin Mesylate in the form of an injection. It contains 1 mg per 2 mL (0.5 mg/mL) of the medication for intravenous use in a single-dose vial. The text also includes storage instructions, dosage details, and a caution that it is a cytotoxic agent. The medication is manufactured by Gland Pharma Limited in Andhra Pradesh, India. Additional details such as lot number, expiry date, and a code are also provided.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.